Natalizumab is associated with stable or improved cognitive function, health-related quality of life, and work capacity in anti-JC virus seronegative patients with early relapsing-remitting multiple sclerosis: a 2-year analysis of STRIVE
MULTIPLE SCLEROSIS JOURNAL(2017)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要